Brean Murray initiates coverage on ImmunoGen, Inc. (NASDAQ: IMGN) at Buy with a price target of $14.

"Despite the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE